Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Harold Y. | - |
dc.contributor.author | Mei, Jianping | - |
dc.date.accessioned | 2008-05-30T13:32:15Z | - |
dc.date.available | 2008-05-30T13:32:15Z | - |
dc.date.issued | 1994-12-06 | - |
dc.identifier.uri | http://hdl.handle.net/2451/27259 | - |
dc.description.abstract | Little work has been done to characterize the empirical effects of political events on financial markets. In this paper we attempt to measure the impact of political risk on asset prices, focusing on the Hong Kong equity market. Hong Kong serves as the ideal case study, for two reasons: the political situation is fluid, unpredictable, and characterized by the occurrence of definitive events, and the market movements are volatile, partially reflecting the political event risk. We focus on the 1989-1993 period, during which political issues such as the question of Hong Kong’s democracy after 1997, China’s most-favored-nation trade status, and China’s human rights development and political reform movement have all contributed to Hong Kong’s stock price movements. Modeling market volatility using a jump-diffusion process finds that the volatility of the benchmark Hang Seng Index is driven by a highly persistent component, punctuated by large jumps which are highly related to political events. These results suggest that the Hong Kong market is affected by both economic and political factors which impact future profitability and investor confidence. | en |
dc.language.iso | en_US | en |
dc.relation.ispartofseries | FIN-94-039 | en |
dc.subject | jump-diffusion process | en |
dc.subject | volatility | en |
dc.subject | democracy | en |
dc.subject | mostfavored-nation trade status | en |
dc.title | Political Risk and Stock Returns: The Case of Hong Kong | en |
dc.type | Working Paper | en |
Appears in Collections: | Finance Working Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
wpa94039.pdf | 1.93 MB | Adobe PDF | View/Open |
Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.